The use of hemospray in portal hypertensive bleeding; a case series

Slides:

Advertisements

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.

Volume 63, Issue 1, Pages (July 2015)

Volume 46, Issue 3, Pages (March 2007)

Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs

Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen

Inflammasomes in liver diseases

Volume 50, Issue 4, Pages (April 2009)

MELD: the holy grail of organ allocation?

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review Christian Thoma, Christopher P. Day, Michael.

m-TOR inhibitors: What role in liver transplantation?

m-TOR inhibitors: What role in liver transplantation?

Primary prevention of variceal haemorrhage: A pharmacological approach

Volume 61, Issue 6, Pages (December 2014)

Volume 51, Issue 6, Pages (December 2009)

Reactive oxygen species in the normal and acutely injured liver

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

NS5A inhibitors in the treatment of hepatitis C

Immigration and viral hepatitis

Volume 66, Issue 1, Pages 1-4 (January 2017)

The evidence supports a viral aetiology for primary biliary cirrhosis

Living donor liver transplantation: is the hype over?

Mesenchymal stromal cell therapy for liver diseases

Reply to: “DCD consensus and futility in liver transplantation”

The place of downstaging for hepatocellular carcinoma

Mauro Bernardi, Stefano Gitto, Maurizio Biselli Journal of Hepatology

Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs

Hepatitis C core protein – The “core” of immune deception?

Volume 61, Issue 1, Pages S108-S119 (November 2014)

Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study Gyuri Kim, Suk-Yong Jang, Chung.

Volume 61, Issue 1, Pages S69-S78 (November 2014)

Volume 62, Issue 3, Pages (March 2015)

Darius Moradpour, Arash Grakoui, Michael P. Manns

Volume 59, Issue 3, Pages (September 2013)

Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore

EASL Clinical Practice Guidelines: Wilson’s disease

Roberto de Franchis, Aleksander Krag Journal of Hepatology

Use of hemospray for non-variceal esophageal bleeding in an infant

Volume 57, Issue 5, Pages (November 2012)

Volume 50, Issue 4, Pages (April 2009)

Support Your Specialty

Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong

Paul C. Adams, James C. Barton Journal of Hepatology

Chetana Lim, Chady Salloum, Daniel Azoulay

Immigration and viral hepatitis

The potential of induced pluripotent stem cell derived hepatocytes

Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability Markus Cornberg,

Global burden of alcoholic liver diseases

HCV targeting of patients with cirrhosis

The impact of intestinal microflora on serum bilirubin levels

Volume 63, Issue 1, Pages (July 2015)

Familial amyloidosis: Great progress for an orphan disease

Volume 51, Issue 2, Pages (August 2009)

Volume 62, Issue 3, Pages (March 2015)

Volume 66, Issue 4, Pages (April 2017)

m-TOR inhibitors: What role in liver transplantation?

Shunt dysfunction: Is it suitable as the primary end point in transjugular intrahepatic portosystemic shunt trials? Jingzhi Cai, Wengang Guo, Chuangye.

Liver transplantation in children

Ana Lleo, M. Eric Gershwin, Alberto Mantovani, Pietro Invernizzi

Pathogenesis of cholestatic hepatitis C

Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: Insights from next generation DNA sequencing Roongruedee Chaiteerakij,

Donor-recipient matching: Myths and realities

Chimeric mouse model of hepatitis B virus infection

The relationship between age and fat infiltration in liver and muscle

Genetics of hepatocellular carcinoma: The next generation

MELD: the holy grail of organ allocation?

Thierry Gustot, Rajiv Jalan Journal of Hepatology

Volume 64, Issue 6, Pages (June 2016)

Fondaparinux (Arixtra∗) hepatotoxicity in a 6 year-old child

Presentation transcript:

The use of hemospray in portal hypertensive bleeding; a case series L.A. Smith, A.J. Morris, A.J. Stanley Journal of Hepatology Volume 60, Issue 2, Pages 457-460 (February 2014) DOI: 10.1016/j.jhep.2013.10.008 Copyright © 2013 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Bleeding antral portal hypertensive gastropathy. (A) Pre hemospray application. (B) Post hemospray application. Journal of Hepatology 2014 60, 457-460DOI: (10.1016/j.jhep.2013.10.008) Copyright © 2013 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Bleeding from antral portal hypertensive gastropathy despite APC. (A) Pre hemospray application. (B) Post hemospray application. Journal of Hepatology 2014 60, 457-460DOI: (10.1016/j.jhep.2013.10.008) Copyright © 2013 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Actively bleeding portal hypertensive colopathy. (A) Pre hemospray application. (B) Post hemospray application. Journal of Hepatology 2014 60, 457-460DOI: (10.1016/j.jhep.2013.10.008) Copyright © 2013 European Association for the Study of the Liver Terms and Conditions

Fig. 4 Actively bleeding portal hypertensive gastropathy in the upper body. (A) Pre hemospray application. (B) Post hemospray application. Journal of Hepatology 2014 60, 457-460DOI: (10.1016/j.jhep.2013.10.008) Copyright © 2013 European Association for the Study of the Liver Terms and Conditions